Polly Atkin
@pollyrowena.bsky.social
6.9K followers
1.6K following
1.3K posts
Writer, Lake-swimmer, Bookseller.
FRSL
hEDS/Haemochromatosis/all the comorbs
she/her
rep @PortyLiterary
Basic Nest Architecture
Much with Body
Recovering Dorothy
Some Of Us Just Fall
The Company of Owls
https://linktr.ee/pollyatkin
Posts
Media
Videos
Starter Packs
Pinned
Polly Atkin
@pollyrowena.bsky.social
· Aug 26
Nature is Not Going to Cure You: On Raynor Winn’s Fabricated Memoir
Like many writers, I have been following the unfolding revelations about Raynor Winn and The Salt Path with great interest, and a degree of self-interest. I am a memoirist and nature writer, and I …
lithub.com
Reposted by Polly Atkin
Reposted by Polly Atkin
Reposted by Polly Atkin
Reposted by Polly Atkin
Reposted by Polly Atkin
Reposted by Polly Atkin
Reposted by Polly Atkin
Reposted by Polly Atkin
The Guardian
@theguardian.com
· 14h
UK universities offered to monitor students’ social media for arms firms, emails show
Loughborough, Heriot-Watt and Glasgow corresponded with companies concerned about campus protests
Universities in the UK reassured arms companies they would monitor students’ chat groups and social media accounts after firms raised concerns about campus protests, according to internal emails.
One university said it would conduct “active monitoring of social media” for any evidence of plans to demonstrate against Rolls-Royce at a careers fair. Continue reading...
www.theguardian.com
The Guardian
@theguardian.com
· 14h
NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump
UK ministers seek to end pricing row with pharma industry cited as reason for firms axing projects
Ministers are preparing to raise the amount the NHS pays pharmaceutical firms for medicines by up to 25% after weeks of intensive talks with the Donald Trump administration and drugmakers.
The government has drawn up fresh proposals to end a standoff with the industry over drug pricing, including changing the cost-effectiveness thresholds under which new medications are assessed for use on the NHS, according to industry sources. Continue reading...
www.theguardian.com
Reposted by Polly Atkin